A detailed history of Exane Derivatives transactions in Icu Medical Inc stock. As of the latest transaction made, Exane Derivatives holds 1 shares of ICUI stock, worth $170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$170
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$220.96 - $247.44 $49,936 - $55,921
-226 Reduced 99.56%
1 $0
Q3 2021

Oct 26, 2021

SELL
$186.8 - $260.0 $14,757 - $20,540
-79 Reduced 25.82%
227 $52,000
Q2 2021

Jul 28, 2021

SELL
$190.83 - $215.73 $180,334 - $203,864
-945 Reduced 75.54%
306 $62,000
Q1 2021

Apr 30, 2021

BUY
$197.58 - $222.54 $14,620 - $16,467
74 Added 6.29%
1,251 $257,000
Q4 2020

Jan 27, 2021

BUY
$177.6 - $214.65 $124,497 - $150,469
701 Added 147.27%
1,177 $252,000
Q3 2020

Oct 06, 2020

BUY
$177.7 - $200.24 $81,386 - $91,709
458 Added 2544.44%
476 $86,000
Q2 2020

Jul 10, 2020

SELL
$172.31 - $230.89 $84,259 - $112,905
-489 Reduced 96.45%
18 $3,000
Q1 2020

Apr 17, 2020

BUY
$160.04 - $216.15 $79,699 - $107,642
498 Added 5533.33%
507 $102,000
Q4 2019

Jan 22, 2020

BUY
$151.88 - $189.51 $759 - $947
5 Added 125.0%
9 $1,000
Q1 2019

Apr 24, 2019

SELL
$221.09 - $253.28 $430,020 - $492,629
-1,945 Reduced 99.79%
4 $0
Q4 2018

Jan 31, 2019

BUY
$213.13 - $281.01 $311,596 - $410,836
1,462 Added 300.21%
1,949 $447,000
Q1 2018

Apr 30, 2018

BUY
$213.2 - $261.85 $4,903 - $6,022
23 Added 4.96%
487 $0
Q4 2017

Jan 29, 2018

BUY
$186.1 - $220.45 $86,350 - $102,288
464
464 $0

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $4.08B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.